• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Microbiol Spectr . Sequencing Using a Two-Step Strategy Reveals High Genetic Diversity in the S Gene of SARS-CoV-2 after a High-Transmission Period

tetano

Editor, Senior Moderator
Microbiol Spectr


. 2021 Nov 10;e0063921.
doi: 10.1128/Spectrum.00639-21. Online ahead of print.
Sequencing Using a Two-Step Strategy Reveals High Genetic Diversity in the S Gene of SARS-CoV-2 after a High-Transmission Period in Tunis, Tunisia


Wasfi Fares[SUP] #[/SUP][SUP] 1 [/SUP], Kais Ghedira[SUP] #[/SUP][SUP] 2 [/SUP], Mariem Gdoura[SUP] 1 3 [/SUP], Anissa Chouikha[SUP] 1 [/SUP], Sondes Haddad-Boubaker[SUP] 1 [/SUP], Marwa Khedhiri[SUP] 1 [/SUP], Kaouthar Ayouni[SUP] 1 [/SUP], Asma Lamari[SUP] 1 [/SUP], Henda Touzi[SUP] 1 [/SUP], Walid Hammemi[SUP] 1 [/SUP], Zina Medeb[SUP] 1 [/SUP], Amel Sadraoui[SUP] 1 [/SUP], Nahed Hogga[SUP] 1 [/SUP], Nissaf Ben Alaya[SUP] 4 5 [/SUP], Henda Triki[SUP] 1 5 [/SUP]



Affiliations

Abstract

Recent efforts have reported numerous variants that influence severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral characteristics, including pathogenicity, transmission rate, and detectability by molecular tests. Whole-genome sequencing based on next-generation sequencing technologies is the method of choice to identify all viral variants; however, the resources needed to use these techniques for a representative number of specimens remain limited in many low- and middle-income countries. To decrease sequencing costs, we developed a primer set allowing partial sequences to be generated in the viral S gene, enabling rapid detection of numerous variants of concern (VOCs) and variants of interest (VOIs); whole-genome sequencing is then performed on a selection of viruses based on partial sequencing results. Two hundred one nasopharyngeal specimens collected during the decreasing phase of a high-transmission COVID-19 wave in Tunisia were analyzed. The results reveal high genetic variability within the sequenced fragment and allow the detection of first introductions in the country of already-known VOCs and VOIs, as well as other variants that have interesting genomic mutations and need to be kept under surveillance. IMPORTANCE The method of choice for SARS-CoV-2 variant detection is whole-genome sequencing using next-generation sequencing (NGS) technologies. Resources for this technology remain limited in many low- and middle-income countries, where it is not possible to perform whole-genome sequencing for representative numbers of SARS-CoV-2-positive cases. In the present work, we developed a novel strategy based on a first partial Sanger screening in the S gene, which includes key mutations of the already known VOCs and VOIs, for rapid identification of these VOCs and VOIs and to help better select specimens that need to be sequenced by NGS technologies. The second step consists of whole-genome sequencing to allow a holistic view of all variants within the selected viral strains and confirm the initial classification of the strains based on partial S gene sequencing.

Keywords: COVID-19; SARS-CoV-2; Tunisia; VOCs; VOIs; spike protein; whole-genome sequencing.
 
Back
Top Bottom